Founded in 2020 by infusion-pump veterans Jason Maine and Roger Hungerford, Amgis is a privately funded, engineer-led company focused on rethinking electronic IV therapy. After five years and $25 million in self-funded research and development, the company is preparing its first infusion system for FDA review, with the goal of addressing longstanding flow-measurement problems for clinicians and patients.
FDA 510(k) submission
compliance_program
ISO 13485
compliance_program
21 CFR Part 820
compliance_program